Craft

Bukwang Pharmaceutical

Stock Price

₩4.9 K

2024-10-29

Market Capitalization

₩334.1 B

2024-10-29

Revenue

₩125.9 B

FY, 2023

Bukwang Pharmaceutical Summary

Company Summary

Overview
Bukwang Pharmaceutical is a company that specializes in the field of drug development. It offers a range of medications for the treatment of central nervous system (CNS), respiratory, liver, and diabetic diseases. The company is also engaged in the development of drug candidates to address oncology and immune disorders.
Type
Public
Status
Active
Founded
1960
HQ
seoul, KR | view all locations
Website
https://www.bukwangpharm.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • seoul, Seoul HQ

    Korea (Republic of)

    7-50 Sangdo-dong, Dongjak-gu

Bukwang Pharmaceutical Financials

Summary Financials

Revenue (Q3, 2025)
₩47.8B
Gross profit (Q3, 2025)
₩21.9B
Net income (Q3, 2025)
₩1.5B
Cash (Q3, 2025)
₩29.5B
EBIT (Q3, 2025)
₩1.9B
Enterprise value
$384.8B

Footer menu